Evidence map›Paper›PMID 39769397›Full record

ReviewInternational journal of molecular sciences2024

Epigenetic Biomarkers in Thrombophilia-Related Pregnancy Complications: Mechanisms, Diagnostic Potential, and Therapeutic Implications: A Narrative Review.

Claudia Ramona Bardan, Ioana Ioniță, Maria Iordache, Despina Călămar-Popovici, Violeta Todorescu, Roxana Popescu, Brenda Cristiana Bernad, Răzvan Bardan, Elena Silvia Bernad

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Circadian clock regulation of hemostasis: a systematic review of molecular pathways.Research and practice in thrombosis and haemostasis · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Claudia Ramona BardanDoctoral School, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Ioana IonițăClinic of Hematology, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania.ORCID 0000-0002-6840-9553
Maria IordacheClinic of Hematology, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania.
Despina Călămar-PopoviciClinic of Hematology, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania.
Violeta TodorescuClinic of Hematology, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania.
Roxana PopescuDivision of Cell and Molecular Biology, Department of Microscopic Morphology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.ORCID 0000-0002-9387-1141
Brenda Cristiana BernadDoctoral School, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Răzvan BardanDepartment of Urology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Elena Silvia BernadDepartment of Obstetrics and Gynecology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.ORCID 0000-0003-1084-2714

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnancy complications associated with thrombophilia represent significant risks for maternal and fetal health, leading to adverse outcomes such as pre-eclampsia, recurrent pregnancy loss, and intra-uterine growth restriction (IUGR). They are caused by disruptions in key physiological processes, including the coagulation cascade, trophoblast invasion, angiogenesis, and immune control. Recent advancements in epigenetics have revealed that non-coding RNAs, especially microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and extracellular vesicles (EVs) carrying these RNAs, play crucial roles in the regulation of these biological processes. This review aims to identify the epigenetic biomarkers that are the best candidates for evaluating thrombophilia-related pregnancy complications and for assessing the efficacy of anticoagulant and antiaggregant therapies. We emphasize their potential integration into personalized treatment plans, aiming to improve the risk assessment and therapy strategies for thrombophilic pregnancies. Future research should focus on validating these epigenetic biomarkers and establishing standardized protocols to enable their integration into clinical practice, paving the way for a precision medicine approach in obstetric care.

Indexed as

BiomarkersEpigenesis, GeneticThrombophiliaFemaleHumansMicroRNAsPregnancyPregnancy Complications, HematologicBiomarkersMicroRNAsepigenetic biomarkersextracellular vesicleslncRNAmiRNApregnancythrombophilia

Identifiers

PMID39769397
PMCPMC11728153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.